Por favor, use este identificador para citar o enlazar este ítem:
http://sgc.anlis.gob.ar/handle/123456789/467
Título : | NF-kappa B activation is involved in regulation of cystic fibrosis transmembrane conductance regulator (CFTR) by interleukin-1 beta | Autor : | Cafferata, Eduardo González Guerrico, Anatilde M. Pivetta, Omar H. Santa-Coloma, Tomás A. |
Palabras clave : | Fibrosis Quística;Interleucina-1beta;Regulador de Conductancia de Transmembrana de Fibrosis Quística;Ensayo de Cambio de Movilidad Electroforética | Fecha de publicación : | 4-may-2001 | Journal: | The Journal of biological chemistry | Resumen : | Interleukin-1 beta (IL-1 beta) regulates the levels of cystic fibrosis transmembrane conductance regulator (CFTR) mRNA and protein in the T84 human carcinoma cell line. Here, we studied the role of the transcription factor NF-kappaB in this regulation. Initially, T84 cells were pretreated with the NF-kappaB inhibitor pyrrolidine dithiocarbamate, Cells were then stimulated with IL-1 beta, and CFTR mRNA levels were determined after 4 h by Northern blot analysis. As a result of PDTC treatment, IL-1 beta stimulation of CFTR mRNA was blocked, On the other hand, daunorubicin, an NF-kappaB activator, increased the steady-state levels of CFTR mRNA, Furthermore, after treatment with IL-1 beta for 1 h, cytoplasmic I kappaB alpha degradation occurred simultaneously with translocation of p65 into the nucleus, The T84 cells were also transduced with an adenoviral vector expressing a dominant negative form of I kappaB alpha, which prevents I kappaB alpha phosphorylation and the subsequent nuclear translocation of NF-kappaB, After viral transduction, the cells were stimulated with IL-1 beta for 4 h, and CFTR mRNA levels were measured by Northern blot analysis. The stimulation of CFTR, induced by IL-1 beta, was also blocked in the presence of the dominant negative mutant. These results indicate that NF-kappaB is involved in the pathway by which IL-1 beta regulates CFTR. |
Descripción : | Fil: Cafferata, Eduardo. ANLIS Dr.C.G.Malbrán. Centro Nacional de Genética Médica Dr. Eduardo Castilla. Departamento de Genética Experimental; Argentina. Fil: González Guerrico, Anatilde M. ANLIS Dr.C.G.Malbrán. Centro Nacional de Genética Médica Dr. Eduardo Castilla. Departamento de Genética Experimental; Argentina. Fil: Pivetta, Omar H. ANLIS Dr.C.G.Malbrán. Centro Nacional de Genética Médica Dr. Eduardo Castilla. Departamento de Genética Experimental; Argentina. Fil: Santa-Coloma, Tomás A. ANLIS Dr.C.G.Malbrán. Centro Nacional de Genética Médica Dr. Eduardo Castilla. Departamento de Genética Experimental; Argentina. |
URI : | http://sgc.anlis.gob.ar/handle/123456789/467 | DOI: | 10.1074/jbc.M010061200 | Derechos: | Open Access Creative Commons Attribution 4.0 International License |
Aparece en las colecciones: | Preproducción Publicaciones CeNaGeM |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
TheJournalofbiologicalchemistry_2001_276_18_p15441-p15444.pdf | 383.19 kB | Adobe PDF | Visualizar/Abrir |
Visualizaciones de página(s)
79
comprobado en 19-abr-2024
Descarga(s)
2
comprobado en 19-abr-2024
Google ScholarTM
Consultar
Altmetric
Altmetric
Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons